Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.
Rudolf A WernerSusanne LütjeBilêl HabachaLena BundschuhTakahiro HiguchiAndreas K BuckAleksander KosmalaConstantin LapaMarkus EsslerMartin A LodgeKenneth J PientaMario A EisenbergerMark C MarkowskiMichael A GorinMartin G PomperSteven P RoweRalph A BundschuhPublished in: The Prostate (2023)
in the liver or parotid glands. This may have implications for both PSMA-targeted imaging and treatment, as patient selection for radioligand therapy and standardized frameworks for scan interpretation (PROMISE, E-PSMA) rely on uptake in those reference organs.